ArticleBritish journal of cancer2018

Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma.

Hailong Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.